EVELO BIOSCIENCES INC (EVLO) Stock News

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Mentions: BCLI BIOL TENX CYTO ...

12 Health Care Stocks Moving In Friday's Intraday Session

Mentions: SCLX SNES LPTX MODD ...

Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis

- Primary endpoint was not achieved – - Company exploring strategic alternatives and partnering opportunities for EDP1815 and its SINTAX platform - ...

Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis

Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights

– EDP2939 Phase 2 trial in moderate psoriasis fully enrolled with topline data expected early Q4 2023– Completed $25.5 Million Private Placement–...

Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights

Evelo Biosciences Closes $25.5 Million Private Placement

Restructures and reduces secured debt with Horizon Technology Finance Corporation Appoints two new members and decreases size of Board of Directors ...

Evelo Biosciences Closes $25.5 Million Private Placement